FNDC10: A Unique Protein Involved in Cell Signaling Pathways (G643988)

Target Name: FNDC10

NCBI ID: G643988

FNDC10

Other Name(s): fibronectin type-III domain-containing transmembrane protein C1orf233 | C1orf233 | fibronectin type III domain containing 10 | FND10_HUMAN | Fibronectin type III domain containing 10 | Fibronectin type-III domain-containing transmembrane protein C1orf233 | Fibronectin type III domain-containing protein 10

FNDC10: A Unique Protein Involved in Cell Signaling Pathways

FNDC10, also known as fibronectin type-III domain-containing transmembrane protein C1orf233, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the superfamily of transmembrane proteins, which are proteins that span the cell membrane and extend into the cytoplasm. FNDC10 is unique due to its unique structure and the specific functions it is known to have.

One of the defining features of FNDC10 is its ability to interact with other proteins that are expressed in the same cell or tissue. This interaction is known as dimerization, and it allows FNDC10 to form a complex with other proteins that can influence a variety of cellular processes. One of the most well-known functions of FNDC10 is its role in cell adhesion and migration.

FNDC10 is a protein that is expressed in many different tissues throughout the body, including the skin, the lungs, the heart, and the brain. It is also highly expressed in the placenta, which is the site where a developing fetus implants and receives oxygen and nutrients from the mother. This suggests that FNDC10 may be involved in the process of fetal development and growth.

In addition to its role in cell adhesion and migration, FNDC10 is also known to play a role in the regulation of cell signaling pathways. This is done through its ability to interact with other proteins that are involved in signaling pathways, such as the TGF-β pathway. The TGF-β pathway is a well-known regulator of cell growth and differentiation, and it is involved in many cellular processes, including cell adhesion, migration, and invasion.

FNDC10 is also known to play a role in the regulation of cell signaling pathways related to inflammation. This is done through its ability to interact with other proteins that are involved in inflammation, such as the NF-kappa-B pathway. The NF-kappa-B pathway is a well-known regulator of inflammation and immune responses, and it is involved in many cellular processes that are related to inflammation.

In addition to its role in cell signaling pathways, FNDC10 is also known to play a role in the regulation of cell death. This is done through its ability to interact with other proteins that are involved in cell death, such as the Bcl-2 pathway. The Bcl-2 pathway is a well-known regulator of cell death, and it is involved in many cellular processes that are related to cell death.

FNDC10 is also known to play a role in the regulation of cell signaling pathways related to cell cycle progression. This is done through its ability to interact with other proteins that are involved in cell cycle progression, such as the G1/S transition. The G1/S transition is a well-known stage of the cell cycle where cells prepare for cell division. FNDC10 is involved in the regulation of this transition, which is critical for the maintenance of cellular processes that are necessary for growth and development.

In conclusion, FNDC10 is a unique protein that is involved in a variety of cellular processes. Its ability to interact with other proteins and its specific functions, such as its role in cell adhesion, migration, and signaling pathways, make it an attractive drug target or biomarker. Further research is needed to fully understand the role of FNDC10 in cellular processes and to develop effective treatments for a variety of diseases.

Protein Name: Fibronectin Type III Domain Containing 10

The "FNDC10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FNDC10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets